-
sodium (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
-
ChemBase ID:
105794
-
Molecular Formular:
C16H15N2NaO6S2
-
Molecular Mass:
418.41987
-
Monoisotopic Mass:
418.02692249
-
SMILES and InChIs
SMILES:
[Na+].O=C1N2C(=C(CS[C@@H]2[C@@H]1NC(=O)Cc1sccc1)COC(=O)C)C(=O)[O-]
Canonical SMILES:
CC(=O)OCC1=C(C(=O)[O-])N2[C@H](SC1)[C@@H](C2=O)NC(=O)Cc1cccs1.[Na+]
InChI:
InChI=1S/C16H16N2O6S2.Na/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10;/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23);/q;+1/p-1/t12-,15-;/m1./s1
InChIKey:
VUFGUVLLDPOSBC-XRZFDKQNSA-M
-
Cite this record
CBID:105794 http://www.chembase.cn/molecule-105794.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
sodium (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
(6R,7R)-3-[(Acetyloxy)methyl]-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
|
7-(2-Thienylacetamido)cephalosporanic Acid
|
7-(Thiophene-2-acetamido)cephalosporin
|
7-[2-(2-Thienyl)acetylamido]cephalosporanic Acid
|
CT
|
Cefalotin
|
Cephalotin
|
Cephalothin
|
7-(2-Thienylacetamido)cephalosporanic acid sodium salt
|
Cephalotin sodium salt
|
Cephalothin sodium salt
|
7-[2-Thienylacetamido]-cephalosporanic acid
|
CEPHALOTHIN SODIUM SALT
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
3.625907
|
H Acceptors
|
5
|
H Donor
|
1
|
LogD (pH = 5.5)
|
-1.8540871
|
LogD (pH = 7.4)
|
-3.3175669
|
Log P
|
0.016272906
|
Molar Refractivity
|
104.6311 cm3
|
Polarizability
|
36.26567 Å3
|
Polar Surface Area
|
115.84 Å2
|
Rotatable Bonds
|
7
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
MP Biomedicals
Sigma Aldrich
TRC
Sigma Aldrich -
C4520
|
Biochem/physiol Actions Cephalothin is a first-generation cephalosporin antibiotic that disrupts the synthesis of the peptidoglycan layer of bacterial cell walls. It is effective against gram-positive and gram-negative bacteria. Mode of Resistance: Cephalosporinase production. Mode of Action: Inhibits cell wall synthesis.Antimicrobial spectrum: Gram-positive cocci.Mode of Resistance: Cephalosporinase production. Other Notes First generation cephalosporin antibiotic. Application Cephalothis is used to study the mechanism of liposome encapsulated antibiotics 1, strategies for co-opting β-lactamases of Gram-negative bacteria for treatment of antibiotics 2, and for immunology studies in relation to antibiotics 3. It is used to study the effect of expression, binding and inhibition of penicillin-binding proteins especially PBP6 on bacterial cell wall mucopeptide synthesis. Protocols & Applications Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information |
Sigma Aldrich -
C3050
|
Biochem/physiol Actions Mode of Action: Inhibits cell wall synthesis.Antimicrobial spectrum: Gram-positive cocci.Mode of Resistance: Cephalosporinase production. Mode of Action: Inhibits cell wall synthesis.Antimicrobial spectrum: Gram-positive cocci.Mode of Resistance: Cephalosporinase production. Other Notes First generation cephalosporin antibiotic. General description Cephalotin is a first generation cephalosporin antibiotic. Protocols & Applications Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information |
Sigma Aldrich -
22241
|
Biochem/physiol Actions Mode of Action: Inhibits cell wall synthesis.Antimicrobial spectrum: Gram-positive cocci.Mode of Resistance: Cephalosporinase production. Other Notes First generation cephalosporin antibiotic. |
Toronto Research Chemicals -
C261150
|
A first generation cephalosporin antibiotic with a wide range antibacterial activity. It is effective against gram-positive and gram-negative bacteria, and has been tested in respiratory disease and neuromuscular junction studies. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Shibata, K., et al.: J. Antibiot., 50, 135 (1997)
- • Farra, A., et al.: Int. J. Antimicrob. Agents., 31, 427 (1997)
- • Pichardo, C., et al.: Eur. J. Clin. Microbiol. Infect. Dis., 30, 289 (1997)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent